Question 1

Purpose of the Test

Accepted Answer

Early detection of bladder cancer in high-risk individuals. Monitoring patients after tumor resection to detect recurrence. Providing complementary data to cystoscopy procedures.

Question 2

Target Groups

Accepted Answer

Current and former smokers. Individuals experiencing blood in the urine (hematuria). Patients with a history of bladder cancer.

Question 3

Frequently Asked Questions

Accepted Answer

Does this test replace cystoscopy? No, it is a complementary test used alongside it. When will results be ready? Typically within 24 to 48 hours.

Early Bladder Cancer Detection - Nuclear Matrix Protein 22 (NMP22) Urine Test